CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT

Not Applicable

Completed

• Conditions: Generalized Anxiety; Stress Disorder, Posttraumatic; Social Anxiety; Major Depression; Panic Disorder

• Registration Number: NCT03015285
• Lead Sponsor: Nova Scotia Health Authority

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-19
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

Inclusion Criteria:<br><br> - Literate<br><br> - High Anxiety Sensitivity (high AS, participants must score =23 on the Anxiety<br> Sensitivity Index - 3)<br><br> - Live in the surrounding area of Halifax, Nova Scotia or Fredericton, New Brunswick<br><br> - Must have a primary diagnosis of one of Agoraphobia, Generalized Anxiety Disorder<br> (GAD), Social Anxiety Disorder (SAD), Panic Disorder (PD), Other Specified Anxiety<br> Disorder, Major Depressive Disorder (MDD), Posttraumatic Stress Disorder (PTSD), or<br> Illness Anxiety Disorder (IAD) according to the Diagnostic and Statistical Manual of<br> Mental Disorders, 5th edition (DSM-5; APA, 2013) as determined by a Structured<br> Clinical Interview for DSM-5 Disorders<br><br>Exclusion Criteria:<br><br> - Must not have any contraindications to physical exercise<br><br> - Must not be engaged in another current psychotherapy as it may interfere with the<br> treatment under investigation<br><br> - Need to be able to attend intervention sessions at Dalhousie University or the<br> University of New Brunswick<br><br> - Must not have current Bipolar Disorder and psychosis nor current suicidal intent

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in anxiety sensitivity: the Anxiety Sensitivity Index - 3 (ASI-3);Change in primary diagnosis (e.g., anxiety disorder or depression) symptoms;Change in comorbid diagnosis (e.g., anxiety disorders or depression) symptoms

Secondary Outcome Measures

Name	Time	Method
Diagnostic status as measured by the Structured Clinical Interview for DSM-5 (SCID-5);General distress as measured by the Depression Anxiety Stress Scale (DASS-21);General distress as measured by the Clinical Outcomes in Routine Evaluation measure (CORE-10);Functional disability as measured by the Sheehan Disability Scale (SDS);Drinking Motives as measured by the Modified Drinking Motives Questionnaire - Revised (MDMQ-R);Hazardous alcohol use as measured by the Alcohol Use Disorders Identification Test (AUDIT);Alcohol-related problems as measured by the Short Inventory of Problems (SIP-2R);Treatment alliance as measured by the Working Alliance Inventory - Short-form (WAI-SR);Treatment satisfaction as measured by several short researcher-generated questions